| Literature DB >> 35370464 |
Yuxin Ran1,2,3, Jie He1,2,3, Ruixin Chen4, Yan Qin5, Zheng Liu1,2,3, Yunqian Zhou1,2,3, Nanlin Yin2,3,6, Hongbo Qi1,7, Wei Zhou7.
Abstract
Recurrent miscarriage (RM) and unexplained infertility (UI) are gordian knots in reproductive medicine, which are troubling many patients, doctors, and researchers. Although these two diseases of early pregnancy have a significant impact on human reproductive health, little is known about the specific mechanisms, which caused treatment difficulties. This study focused on the molecular signatures underlying the pathological phenotypes of two diseases, with the hope of using statistical methods to identify the significant core genes. An unbiased Weighted Correlation Network Analysis (WGCNA) algorithm was used for endometrial transcriptome data analysis and the disease-related gene modules were screened out. Through enrichment analysis of the candidate genes, we found similarities between both diseases and shared enrichment of immune-related pathways. Therefore, we used immune algorithms to assess the infiltration of immune cells and found abnormal increases of CD8+T cells and neutrophils. In order to explore the molecular profile behind the immunophenotypic changes, we used the SVM algorithm and LASSO regression to identify the core genes with diagnostic capacity in both diseases and discussed their significance of immune disorders in the endometrium. In the end, the satisfactory diagnostic ability of these core genes was verified in the broader group. Our results demonstrated the presence of immune disorders in non-pregnancy tissues of RM and UI, and identified the core molecules of this phenotype, and discuss mechanisms. This provides exploratory evidence for the in-depth understanding of the mechanism of RM and UI and may provide potential targets for their future treatment. © The author(s).Entities:
Keywords: Endometrium; Molecular characteristics; Recurrent miscarriage; Transcriptome analysis.; Unexplained infertility
Mesh:
Year: 2022 PMID: 35370464 PMCID: PMC8964333 DOI: 10.7150/ijms.69648
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Figure 1Weighted Co-Expression Network Construction and Identification of Key Modules. (A) Determination of soft-threshold power in the WGCNA. (B) Clustering dendrograms showing 10 modules containing highly connected genes. (C) Heatmap of the correlation between the modules and clinical diagnosis. (D) Heatmap of the gene expression in the candidate modules of RM group (left panel) and UI group (right panel). (NC: n = 12; RM: n = 12; UI: n = 12)
Figure 2Biological function enrichment analysis of genes in candidate modules. Dot plot of biological function enrichment of the genes in RM candidate modules (A) and UI candidate modules (B).
Figure 3Composition of infiltrated immune cells between case group and control. (A) Stacked bar chart showing the composition of infiltrated immune cells. (B) Violin diagram showing significant difference in immune cell types. (NC: n = 12; RM: n = 12; UI: n = 12) (* indicates P < 0.05; ** indicates P < 0.01, ns indicates no significant difference)
Figure 4Identification of core characteristic genes. Top-ranked genes by their discriminant ability in the SVM algorithm step for RM (A) and UI (C). Coefficient profile plot showing the selection of the optimal parameter (lambda) in the LASSO model for RM (B) and UI (D). Identified core genes after integrating algorithm for RM (E) and UI (F). (NC: n = 12; RM: n = 12; UI: n = 12) (*** indicates P < 0.001)
Figure 5Separating capability of the core characteristic gene model. ROC curve of the diagnostic signature in the training group for RM (A) and UI (B). Nanogram of the core characteristic gene model for RM (C) and UI (D). (NC: n = 12; RM: n = 12; UI: n = 12)
Figure 6Internal validation of the candidate genes in RM and UI. (A) Heatmap of the core genes expression in each group. Expression of RM core genes (B) and UI core genes (D) in their respective group. ROC curve of core genes of RM (C) and UI (E). (NC: n = 24; RM: n = 24; UI: n = 24) (*** indicates P < 0.001)
Figure 7External validation of the candidate genes in RM and UI. Expression level (A) and ROC curve (C) of RM core genes (NC: n = 28; RM: n = 21). Expression level (B) and ROC curve (D) of UI core genes (NC: n = 92; RM: n = 63). (*** indicates P < 0.001, ns indicates no significant difference)